Overcoming Barriers to TB Control
Training Curriculum
August 2011
Au cours des dix dernières années, les ONG humanitaires ont fait de plus en plus fréquemment appel aux Entreprises de sécurité privées (ESP). On observe l’existence d’un écart entre la manière dont les ONG utilisent les ESP dans la réalité et la régulation d’une telle relation. Ces ...orientations ont pour objet d’aider les ONG humanitaires à prendre une décision en connaissance de cause sur quand, comment et dans quelles conditions, recourir aux services d’une ESP. Ces orientations sont destinées aux responsables opérationnels des ONG au niveau du siège et du terrain. Ces orientations ne couvrent pas uniquement des activités de surveillance ou de protection armées, mais peuvent être appliquées à une gamme plus étendue de services assurés par les ESP.
more
Lessons from the Africa Regional Stigma Training Programme
Supporting community action on AIDS in developing countries
Recommendations for a public health approach
HIV/AIDS Programme
This report explores the access to healthcare granted to irregular migrants in 10 EU Member States. It focuses on migrants who are present in an irregular situation, namely those who do not fulfil conditions for entry, stay or residence. Through interviews with a range of different sources including... public authorities at the national and local level, health professionals, non-governmental organisations (NGOs) providing helathcare and irregular migrants themselves, this report documents the legal, economic and practical obstacles that hinder migrants' access to healthcare.
For versions in French, Polish, German and Swedish check also http://fra.europa.eu/de/publication/2012/migranten-einer-irregulren-situation-zugang-zu-medizinischer-versorgung-zehn
more
In preparing this paper, the Pharmacovigilance Group of the Pan American Health Organization’s Pan American Network for Drug Regulatory Harmonization (PANDRH) adopted the perspective of PAHO/WHO, which considers Pharmacovigilance, an essential component of public health programs. Its intention was... to facilitate the development of pharmacovigilance systems in the Region of the Americas and improve, strengthen, and promote the adoption of good practices to improve safety for patients and the general population, based on the needs of the Region.
Document also available in Spanish and Portuguese!
more
International Journal of Mental Health Systems2011,5:17http://www.ijmhs.com/content/5/1/17
This guide presents new knowledge and guidelines on the provision of care to persons living with HIV/AIDS, in accordance with the last guidelines of the World Health Organization (WHO) published in 2006 and adapted to the Rwandan national context. It thus responds to the need by the Ministry of Heal...th to improve the skills of the actors in the health sector as well as the quality of care and antiretroviral treatment offered in both public and private health facilities countrywide.
more
Therapeutics Information and Pharmacovigilance Centre | TIPC
HRH Strategy for the Health Sector: 2012/13 – 2016/17
South Africa has faced many challenges over the past two decades, accomplishing profound positive changes in the social structure and government of the nation. This has not yet fully translated into better health for the population, however, particularly the poorest segment. In fact, the p...opulation has lost ground since the 1990s in virtually all important health indicators, leaving South Africa with a high burden of infectious disease.
August 2011, Vol. 101, No. 8 SAMJ
more
In Kenya, the bacterial infections that contribute most to human disease are often those in which re-‐sistance is most evident. Examples are multidrug-‐resistant enteric bacterial pathogens such as typhoid, ... diarrhoeagenic Escherichia coli and invasive non-‐typhi salmonella, penicillin-‐resistant Streptococcus pneu-‐moniae, vancomycin-‐resistant enterococci, methicillin-‐resistant Staphylococcus aureus and multidrug-‐re-‐sistant Mycobacterium tuberculosis. Resistance to medicines commonly used to treat malaria is of particu-‐lar concern, as is the emerging resistance to anti-‐HIV drugs. Often, more expensive medicines are required to treat these infections, and this becomes a major challenge in resource-‐poor settings.
more